| Literature DB >> 21073335 |
Gerard Karsenty1, Vijay K Yadav.
Abstract
The molecular elucidation of two human skeletal dysplasias revealed that they are caused by an increase or a decrease in the synthesis of serotonin by enterochromaffin cells of the gut. This observation revealed a novel and powerful endocrine means to regulate bone mass. Exploiting these findings in the pharmacological arena led to the demonstration that inhibiting synthesis of gut-derived serotonin could be an effective means to treat low-bone-mass diseases such as osteoporosis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21073335 DOI: 10.1146/annurev-med-090710-133426
Source DB: PubMed Journal: Annu Rev Med ISSN: 0066-4219 Impact factor: 13.739